BioLife Solutions appoints Timothy L. Moore to board of directors effective Sept 1, 2022

BIOLIFE SOLUTIONS INC

Moore brings 30+ years biopharma ops experience; served as EVP Technical Ops at Kite Pharma (Gilead) and head of Genentech biologics ops.
Moore also serves on Cerus Corporation (CERS) board.
Appointed to Compensation Committee and Nominating and Governance Committee.
Board expands to six members; Moore qualifies as independent under Nasdaq rules.
No related-party transactions requiring disclosure; compensation same as other non-employee directors.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Tim Moore

Director

BLFS · BIOLIFE SOLUTIONS INC

Effective: 2022-09-01
Filed: August 26, 2022, 7:59 PM ET

Effective September 1, 2022, the board of directors (the “Board”) of BioLife Solutions, Inc. (the “Company”) appointed Tim Moore to the Board

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Tim Moore was appointed as Director at BIOLIFE SOLUTIONS INC.

Action: appointed
Role: Director

Exact text from the filing

Effective September 1, 2022, the board of directors (the “Board”) of BioLife Solutions, Inc. (the “Company”) appointed Tim Moore to the Board

View on SEC.gov

BIOLIFE SOLUTIONS INC filing history →

Source: SEC EDGAR

accession 0001437749-22-021377

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.